Sotera Health (NASDAQ:SHC) Shares Down 5.9% – Here’s Why

Sotera Health Company (NASDAQ:SHC)’s share price was down 5.9% during mid-day trading on Tuesday . The company traded as low as $14.26 and last traded at $14.4750. Approximately 1,936,603 shares changed hands during trading, a decline of 23% from the average daily volume of 2,505,838 shares. The stock had previously closed at $15.39.

Sotera Health News Roundup

Here are the key news stories impacting Sotera Health this week:

• Positive Sentiment: Q1 results beat expectations: reported revenue $280.05M (+10% YoY) and EPS $0.18 (vs. consensus $0.17); adjusted EBITDA and adjusted EPS improved, supporting margin expansion and the company’s reaffirmed FY outlook. Sotera Health Delivers Strong First-Quarter 2026 Results and Reaffirms 2026 Outlook
• Positive Sentiment: Media coverage emphasized the upside reaction to the beats, noting strong top‑line growth and investor interest following the print. Sotera Health Company’s (NASDAQ:SHC) Q1 CY2026: Beats On Revenue, Stock Soars
• Positive Sentiment: Short‑term momentum commentary highlights strength versus broader Nasdaq futures, suggesting investor focus on the company’s operational beats and improving fundamentals. Sotera Health Momentum Builds Beyond Nasdaq Futures Trends
• Neutral Sentiment: FY 2026 guidance affirmed: company gave EPS range $0.93–$1.01 and revenue target roughly $1.2B–$1.3B. The range overlaps street estimates (consensus ~$0.95 EPS) but is wide, leaving room for interpretation on full‑year visibility. Sotera Health Delivers Strong First-Quarter 2026 Results and Reaffirms 2026 Outlook
• Neutral Sentiment: Earnings call transcript and slide deck are available for details on backlog, pricing, and regional trends — useful for investors who want color on margin drivers and organic vs. acquisition growth. Sotera Health Company (SHC) Q1 2026 Earnings Call Transcript
• Neutral Sentiment: Analyst write‑ups (Zacks, others) confirm the beat but dig into metric comparisons vs. street estimates and prior year, useful for model adjustments rather than signaling a directional surprise. Sotera Health (SHC) Q1 Earnings: How Key Metrics Compare to Wall Street Estimates
• Negative Sentiment: Planned CEO transition announced: Alton Shader (from Viant Medical) to become CEO on May 26, with current CEO Michael Petras moving to Executive Chairman — a managed handoff but a source of near‑term uncertainty around strategic continuity and execution. Sotera Health Announces Leadership Transition

Wall Street Analysts Forecast Growth

Several analysts have weighed in on the stock. Piper Sandler raised shares of Sotera Health from a “neutral” rating to an “overweight” rating and boosted their target price for the stock from $17.00 to $24.00 in a research report on Friday, January 9th. Wells Fargo & Company downgraded Sotera Health to an “overweight” rating in a research note on Thursday, January 8th. Citigroup boosted their price target on Sotera Health from $21.00 to $23.00 and gave the company a “buy” rating in a report on Tuesday, February 24th. Zacks Research lowered shares of Sotera Health from a “strong-buy” rating to a “hold” rating in a report on Friday, January 30th. Finally, Royal Bank Of Canada assumed coverage on Sotera Health in a research report on Thursday, January 8th. They set an “outperform” rating and a $24.00 target price on the stock. Seven investment analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company’s stock. Based on data from MarketBeat.com, Sotera Health has a consensus rating of “Moderate Buy” and a consensus price target of $20.67.

Sotera Health Price Performance

The company has a market cap of $4.29 billion, a PE ratio of 55.75 and a beta of 1.82. The company has a quick ratio of 2.24, a current ratio of 2.46 and a debt-to-equity ratio of 3.66. The stock has a 50-day simple moving average of $15.04 and a 200 day simple moving average of $16.49.

Sotera Health (NASDAQ:SHC) last announced its quarterly earnings data on Tuesday, May 5th. The company reported $0.18 EPS for the quarter, topping analysts’ consensus estimates of $0.17 by $0.01. Sotera Health had a return on equity of 42.38% and a net margin of 6.70%.The business had revenue of $280.05 million during the quarter, compared to the consensus estimate of $270.78 million. During the same period in the previous year, the company posted $0.14 earnings per share. The business’s revenue for the quarter was up 10.0% on a year-over-year basis. Sotera Health has set its FY 2026 guidance at 0.930-1.010 EPS. Equities analysts expect that Sotera Health Company will post 0.88 EPS for the current year.

Insiders Place Their Bets

In other news, Director Gtcr Investment Xi Llc sold 10,000,000 shares of the business’s stock in a transaction on Friday, March 6th. The shares were sold at an average price of $15.27, for a total transaction of $152,700,000.00. Following the completion of the sale, the director directly owned 12,735,301 shares of the company’s stock, valued at $194,468,046.27. The trade was a 43.98% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. 15.36% of the stock is currently owned by corporate insiders.

Hedge Funds Weigh In On Sotera Health

Several hedge funds and other institutional investors have recently made changes to their positions in the business. IFP Advisors Inc boosted its stake in Sotera Health by 1,105.6% during the fourth quarter. IFP Advisors Inc now owns 1,495 shares of the company’s stock valued at $26,000 after buying an additional 1,371 shares in the last quarter. Rothschild Investment LLC bought a new stake in Sotera Health in the fourth quarter valued at $27,000. True Wealth Design LLC increased its position in Sotera Health by 389.3% in the 4th quarter. True Wealth Design LLC now owns 1,830 shares of the company’s stock valued at $32,000 after buying an additional 1,456 shares in the last quarter. Root Financial Partners LLC raised its position in shares of Sotera Health by 217.5% during the first quarter. Root Financial Partners LLC now owns 2,124 shares of the company’s stock worth $30,000 after purchasing an additional 1,455 shares during the period. Finally, Eurizon Capital SGR S.p.A. bought a new position in shares of Sotera Health in the 4th quarter worth $40,000. 91.03% of the stock is currently owned by institutional investors and hedge funds.

Sotera Health Company Profile

Sotera Health Inc (NASDAQ: SHC) is a global provider of sterilization and laboratory testing services that support the medical device, pharmaceutical, life sciences and consumer product industries. Headquartered in Jacksonville, Florida, the company offers a suite of services designed to ensure products meet rigorous safety and regulatory requirements before reaching market.

Sotera Health operates through three primary service platforms. Its Sterigenics division delivers contract sterilization solutions, including ethylene oxide (EtO), gamma irradiation, electron beam and X-ray technologies.